tm logo
WUXI XDC
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 30 Jan 2024

Last Applicant/ Owned by

PO Box 309, Ugland House

Grand Cayman

KY

KY1-1104

Serial Number

97778983 filed on 02th Feb 2023

Registration Number

N/A

Correspondent Address

ERIC LAMB

FROST BROWN TODD LLP

111 MONUMENT CIRCLE, SUITE 4500

INDIANAPOLIS, IN 46204

Filing Basis

1. intent to use

2. intent to use current

3. filed as use application

4. use application currently

Disclaimer

NO DATA

WUXI XDC

Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of c Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Development of products for others; pharmaceutical drug development services; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the pharmaceutical, biomedicine and biotechnology fields; research and development of antibodies; research and development of conjugated antibodies; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates


First Use Date in General

30th Mar 2021

First Use Date in Commerce

13th May 2021

Class [040]
Treatment & Processing of Materials Services


Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; custom production of pharmaceuticals; custom production of biological preparations; custom manufacturing of antibody-drug conjugates; custom manufacturing of chemical reagents; custom manufacturing of pharmaceutical preparations; custom manufacturing of biomedical preparations; custom manufacture of drug conjugates


First Use Date in General

30th Mar 2021

First Use Date in Commerce

13th May 2021

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemico-pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; drugs for medical purposes, namely, anticancer preparations; biological preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; medicines for human purposes in the nature of bioconjugate preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease; pharmaceutical preparations, substances and compositions, namely, antibody-drug conjugates in the nature of medical diagnostic reagents; pharmaceutical preparations, namely, drug conjugates consisting primarily of pharmaceutical preparations for the treatment of cancer, infectious disease, metabolic disease, and central nervous system disease

Specimens


WUXI XDC specimenWUXI XDC specimenWUXI XDC specimenWUXI XDC specimen

Mark Details


Serial Number

No 97778983

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Jan 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05th Dec 2023PUBLISHED FOR OPPOSITION
05th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01st Nov 2023APPROVED FOR PUB - PRINCIPAL REGISTER
31st Oct 2023ASSIGNED TO EXAMINER
22nd Feb 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19th Feb 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
19th Feb 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
19th Feb 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED